Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Case Report

Co-development of autoimmune hepatitis and Sjögren's syndrome triggered by the administration of herbal medicines

Hyo Jeong Oh, Young Mi Mok, Moon Seong Baek, Ji Kyeong Lee, Bong Soo Seo, Tae Hyeon Kim, Keum Ha Choi, In Kyeom Hwang, Ji Eun Ra, Yong-Reol Oh, Yong Sung Kim, Eun Young Cho, Haak Cheoul Kim, Young Woo Sohn

Clin Mol Hepatol. 2013;19(3):305-308. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.305

View: 11118 Download: 96 Crossref: 5

Review

Drug-induced liver injury: present and future

Ki Tae Suk, Dong Joon Kim

Clin Mol Hepatol. 2012;18(3):249-257. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.249

View: 17594 Download: 303 Crossref: 98

4

Four cases of toxic Liver injury associated with Dictamnus dasycarpus

Jong Soon Jang, M.D., Eui Geun Seo, M.D., Cheol Han, M.D., Hee Bok Chae, M.D., Soon Je Kim, M.D. Jae Dong Lee, M.D. Joon Ho Wang, M.D.

Clin Mol Hepatol. 2008;14(2):206-212. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.206

View: 5413 Download: 68 Crossref: 23

1 |

Viewed By 5185	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5045	MAFLD: How is it different from NAFLD?
Viewed By 4999	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3679	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3641	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search